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Abstract 
Aim 
To systematically review the evidence for clinical ratings systems in the assessment of 
outcomes of UK patients with Lateral Elbow Tendinopathy (LET).  
Methods 
A systematic search was performed in Ovid MEDLINE, Embase and CINAHL. Studies were 
included if they reported the administration of PROMs in UK populations with LET. PROMs 
characteristics and the populations in which they had been used were assessed using a 
structured classification system. PROMs reporting in randomised controlled trials was 
assessed against CONSORT standards (PRO extension). 
Results 
A total of 16 articles were included based on eligibility criteria. Out of seven different 
PROMs, there was evidence of partial validation for five of them. The assessment of 
validity, reliability and responsiveness of all PROMs in LET UK populations extended to just 
20 individual patients. No articles conformed to the CONSORT PRO extension standards.   
Conclusion 
There exists a huge paucity of data on the psychometrics and usability of PROMs in UK LET 
populations.  Without these data, trial design and interpretation of health technology 
assessment are significantly hindered. The high prevalence of this condition allied with the 
significant volume of studies being conducted into novel treatments, highlight the need for 
this knowledge gap to be resolved.   
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Background 
Lateral Elbow Tendinopathy (LET), known more commonly as Tennis Elbow, is a prevalent 
and potentially debilitating condition 
(1, 2)
. Though the condition is regarded as benign and 
self-limiting, absenteeism due to LET in the UK is estimated to cost the economy £27 million 
per annum 
(3)
. With a UK prevalence between 1.5-3% 
(2)
, it is surprising that no clear 
treatment consensus exists 
(4, 5)
. This treatment equipoise has driven a large volume of 
research activity, with over 80 registered trials currently ongoing 
(6)
. However, to be 
confident in our treatments, we must be certain that the outcome measures used in these 
trials truly reflect patient benefit or harm.  
Successful treatment in LET can be regarded as amelioration of pain and return of function. 
Constructs such as these are now commonly quantified through the use of Patient-
Reported Outcome Measures (PROMS). Collaborative work by academics and clinicians has 
crystallised in the development of systematic, robust and valid ways of collecting health 
outcomes from patients that purport to quantify, in a meaningful way, how the patient 
feels their condition affects them 
(7)
. In reference to musculoskeletal pathology, this has 
resulted in numerous PROMs used to quantify the burden of a specific disease, such as the 
use of the Oxford Hip and Knee scores in assessing the outcome of joint arthroplasty 
(8)
.  
Appropriate outcome measures must demonstrate that they are acceptable to patients, 
reliable, valid and responsive (sensitive to change) 
(9)
. When the outcome measure has 
been developed in a different clinical or geographical population, there needs to be 
evidence of equivalence both in a disease-specific and cross-cultural context 
(10)
 
(11)
.  
A structured assessment of outcome measurement in LET in UK populations has not been 
undertaken. This study aimed to address this gap by systematically assessing the outcome 
measures used for measuring PROMs in Lateral Elbow Tendinopathy in a UK population, 
and to assess the reporting of randomised controlled trials using PROMs in LET. Only when 
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valid outcomes have been identified, can recommendations on choice of outcome 
measures for future research be made.   
Materials and Methods 
PRISMA guidelines on the reporting of systematic reviews were followed 
(12)
. All articles 
reporting the development, psychometric evaluation, or use of patient reported outcome 
measures in Lateral Elbow Tendinopathy in UK adults (≥18yrs) were included. Any measures 
of symptoms and functioning in LETs that involved a patient-reported outcome 
measurement (regardless of whether this also contained a physician-reported outcome 
component) were included.  Studies in paediatric populations, case-reports, case-studies 
and conference abstracts were excluded.  
A search strategy was constructed using MeSH and free-text terms (appendix 1). The search 
strategy development was guided by previously published search strategies for systematic 
reviews of interventions in elbow pathology 
(13)
 and for the identification of outcome 
measures 
(14)
, along with terms specifically selected in order to capture names of relevant 
instruments published in previous systematic reviews of elbow-specific rating scales 
(15-18)
. 
The strategy was further adapted to each database through the modification of thesaurus 
terms, wildcards, and truncation. The search was run on the 1
st
 May 2017 in Medline (Ovid 
MEDLINE, 1948 to 2016 & Ovid MEDLINE In-Process & Non-indexed Citations) accessed 
through OVIDSP, Embase (Embase 1974 to 2016) accessed through OVIDSP and CINHAL 
(CINHAL 1981 to 2016) accessed through EBSCO host.  
The screening process was conducted in a step-wise manner. At each stage, one researcher 
(JE) and a further researcher reviewed each title and abstract. In cases of disagreement, the 
article proceeded to the next stage of review to ensure maximum sensitivity.  
At the full-text level, articles were also sub-categorised in two groups to: articles reporting 
primary research on the development and/or psychometric evaluation of PROMs in LET in 
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UK populations (development); and articles reporting the use of outcome measures in 
clinical studies in UK populations (use).   
Data synthesis 
Development articles were classified according to three guiding concepts, using the 
structured classification system proposed by Valderas and Alonso 
(19)
: construct (the 
measurement object), population (based on age, gender, condition and culture) and 
measurement model (dimensionality, metric and adaptability) 
(19)
.  
The assessment of construct denotes, for the purpose of this study, the range of 
characteristics measured by the outcome measure, which are affected by LET. The 
construct analysis has, at its foundation, the conceptual strengths of the Wilson and Cleary 
model 
(20)
, but is also integrated with the theoretical model that underpins the International 
Classification of Functioning, Disability and Health (ICF). A strength of the model that is 
particularly pertinent in the assessment of LET outcome measures, is the systematic 
consideration of intended population of use. Within the axis of population consideration of 
culture is also made, where there is information pertaining to the dyad of language and 
country for which the outcome measures have been devised. 
It should be noted that this system is only descriptive and does not provide any 
fundamental evaluation of measurement properties 
(19)
. But in the early stages of outcome 
measure assessment, this approach provides the clearest method of identifying the 
candidate pool of measures. Only once this is undertaken and deemed to be adequate, can 
a systematic evaluation of measurement properties in a specific population of use be 
undertaken.   
Articles reporting the use of PROMs (use) were peer-reviewed, published articles with 
outcome measure evaluation in a population of LET patients. Date of publication, outcome 
measure(s) chosen and population of use was extracted. For randomised control trials, the 
CONSORT Patient-Reported Outcome (PRO) extension 
(21)
 was used to systematically assess 
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the reporting of outcome measure choice and justification. The original CONSORT 
statement aims to encourage transparent and complete reporting of clinical trials and is 
associated with improved reporting practice 
(22)
.  
An a priori hypothesis was formulated with regard to informed choice of outcome 
measures in UK populations. We hypothesised that articles reporting the use of PROMs 
would more frequently use PROMs for which there would be evidence from studies of 
validation of such measures in UK populations.  
Results 
We identified 7,261 records from the electronic database search. A total of 16 articles met 
the inclusion criteria: five articles reporting the development and/or psychometric 
evaluation of outcome measures in LET-specific patients and 11 articles reporting their use 
in a UK population (fig 1)(Appendix 2).  
Measures  
Five outcome measures were identified that were developed or had undergone 
psychometric evaluation, on UK populations that at least, in part, contain patients with LET 
(Table 1). They were all fully standardised measures that had all been developed for 
measuring symptoms (mainly pain) and functioning in English speaking UK adults of either 
gender. However, only one of them, the Patient-Rated Tennis Elbow Evaluation (PRTEE) was 
LET specific, the remaining instruments were developed as elbow-specific tools designed 
for varying pathologies, but including in their validation a sub-sample of LET patients. Two 
outcome measures were originally developed for UK populations: the Oxford Elbow Score 
(OES) and the Liverpool Elbow Score (LES). The remaining three outcome measures were 
developed in the English language outside of the UK (US, Canada and Australia), but had 
undergone some level of psychometric evaluation in UK populations.  Of note, no 
modification was deemed necessary in the wording or description of the symptoms or 
activities measured for any of those instruments.  
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Only the PRTEE has had its metric properties assessed in a UK cohort that was exclusively 
diagnosed with LET. This was conducted on 57 patients to quantify the Minimally Important 
Difference (MID) of the PRTEE. This study formed part of a larger prospective trial assessing 
microcurrent therapy in LET and analysed data from 57 individuals with clinically and 
sonographically diagnosed LET who all underwent microcurrent therapy. They report a 
weak correlation between the PRTEE and global change scale, but no assessment of 
construct validity or any other metric assessment is undertaken. For the four remaining 
outcome measures, the proportion of patients included within their study cohorts who 
were diagnosed of LET ranged from 11% to 12.7% (Table 1). None were evaluated in more 
than 12 patients, and as multiple measures were reported on the same patients cohorts, 
when all individual patients from these studies were tallied it reveals that this equates to 20 
UK LET patients in total.   
Eleven additional articles reported using PROMs to evaluate disease impact in UK 
populations with LET. These studies were published between 2003 and 2014 (Table 2). Out 
of the five outcome measures for which there had been a previous psychometric 
evaluation, only three were subsequently applied to evaluate LET outcomes (DASH, OES 
and PRTEE). The outcome measures that were not utilised were the LES and the Mayo 
Elbow Performance Score (MEPS). Perhaps more surprisingly, two additional measures 
were used, namely the Nirschl score and the Patient-Rated Wrist Evaluation (PRWE), 
although no evidence on the psychometric properties or even their cross-cultural 
equivalence was available. Overall, the PRTEE (and precursor PRFEQ) was reported six 
times, the DASH four times, the Nirschl score twice, the OES once and the PRWE once. 
Seven of the 11 studies stated that the outcome measure was their study’s primary 
outcome.  
Four of these 11 studies were randomised controlled trials (RCTs). The level of adherence to 
CONSORT standards for reporting PROMs outcomes for RCTS for the four trials suggested 
substantial room for improvement (Table 3). No information was available for three 
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standards for any RCT and only partial information was available for the other two 
standards in a minority of studies.  
Discussion  
This study has identified a lack of evidence with which to inform outcome measure choice 
in Lateral Elbow Tendinopathy in the UK. Future validation of outcome measures in UK 
populations is required in order to be able to ground any recommendations on a firm 
evidence base. Furthermore, some outcome measures are currently being used as primary 
outcomes in UK-based studies in the absence of any evidence for their cross-cultural 
appropriateness and psychometric properties.  
We were able to retrieve at least some evidence of the evaluation of the psychometric 
properties of five outcome measures. The PRTEE is the only measure specifically designed 
for the evaluation of a LET population. All measures attempt to measure the domains of 
function and symptoms in adults. All but the DASH have been designed to assess these 
domains in reference to the elbow exclusively.   
The total reporting of validity, reliability or reproducibility of outcome measures in UK LET 
patients is limited to 20 patients 
(23, 24)
. All of these patients have been embedded in larger 
cohorts containing a heterogeneous group of elbow pathology. Due to the limited size of 
this LET sample, it has been unfeasible for the reporting authors to conduct a standardised 
psychometric assessment of the outcome measures using methods such as COSMIN or 
EMPRO.  
The largest assessment outcome measure utility in UK LET patients was published by 
Poltawski et al 
(25)
 and included 57 patients. Although this is by far the largest sample of LET 
patients of any of the studies included here, outcome interpretability through derivation of 
MCID score was undertaken with no evaluation of other relevant psychometric 
characteristics. The PRTEE was not originally designed for a UK population and no evidence 
of formalised cross-cultural evaluation is presented. This would always be necessary when 
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applying a new instrument to a different population, as the use of language across 
continents, though English in origin, confers both linguistic and cultural differences. But in 
this case the need was additionally increased by the fact that items in the PRTEE had been 
altered prior to administration (the words coffee and milk were removed from the item 
“Lift a full coffee cup or glass of milk to your mouth’, “pants” were replaced by “trousers” 
and “washcloth or wet towel” by “wet cloth”). The authors acknowledge that the altering of 
the outcome measure wording may have altered its measurement properties 
(25)
.  
In many circumstances it will be completely appropriate and even highly advisable to alter 
the wording of outcome measures. However, it should be undertaken under the principles 
of cross-cultural adaptation 
(10, 26)
. It is widely recognised that if a measure is to be used 
across cultures, the items must be both linguistically translated and culturally adapted to 
maintain the content validity of the outcome measure at a conceptual level 
(26)
. Guillemin et 
al 
(27)
 have proposed scenarios that should alert authors to situations where translation or 
adaptation should be undertaken. In the situation of an outcome measure being used in 
another country, but in the same language, cultural adaptation is required. For LET in UK 
populations, this would be the case for the DASH, MEPS, PRTEE and Nirschl outcome 
measures. Of note, the DASH and quickDASH score have been culturally adapted to UK 
English since 2015 
(28)
. To the best of our knowledge, this score had not been utilised in any 
of the identified studies.  
The process of cross-cultural adaptation has been well reported 
(10)
. A 10-stage process 
proposed by the International Society for Pharmacoeconomics and Outcomes Research 
(ISPOR) 
(10)
 involves forward and backwards adaptation by multiple reviewers, cognitive 
interviewing with patient populations and pre-testing of the final questionnaire. Though 
this may be seen as a laborious process, users of measures that have not been rigorously 
adapted must also be aware that language alterations may alter measurement properties. 
Therefore, reference values for group comparison, minimally important difference data or 
power calculations may not be valid in the new cultural context of use.     
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This study has identified that the reporting of outcome measures in UK LET randomised 
controlled trials does not conform to the CONSORT-PRO guidance. Though two of the 
studies were published prior to the guidance publication in 2010, the stark paucity of 
reporting of outcome measure detail is concerning. This lack of reporting is in line with the 
deficits in outcome measure validity highlighted through the Valderas 
(19)
 classification 
system. Though we hypothesised that there would be a preference for outcome measures 
with published validity in the target population, we have identified that with the current 
level of evidence this is not possible. This lack of suitable outcome measures has been 
identified by other authors 
(29, 30)
. Long et al (2015)
(4)
 reported in their National Institute of 
Health Research, Health Technology Assessment review of systematic reviews of 
conservative treatments in LET, that a lack of standardised outcome measures hindered 
interpretation and synthesis of results. They recommend that the inclusion of a patient-
reported measure of upper extremity function in interventional trials would ease results 
synthesis. However, we have identified that the lack of a clear choice within the UK 
population is likely to significantly hinder a researcher’s ability to undertake this. 
The authors acknowledge the inherent limitations of this study. The search strategy may 
have failed to identify all outcome measures used, and the identification of the study 
populations’ nationality in interventional trials can be prone to error. However, attempts 
were made to ensure that the strategy was as robust as possible. Outcomes in LET can be 
measured in numerous ways, including grip strength, pain provocation tests and visual 
analogue scales to mention a few, this may be a highly legitimate method and was not 
assessed as part of this study. The authors feel that this approach is justified owing to the 
increasing view that the ultimate measure of success in health care is whether it helps 
patients from their own point of view 
(31)
. Outcome measures, that quantify patient’s 
health-related quality of life, with particular reference to PROMs, are recommended by 
National bodies across the world, including the NIHR in the UK and FDA in the USA 
(7)
. 
Furthermore, the use of condition-specific PROMs is increasingly common in 
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musculoskeletal medicine and are collected as part of the English NHS PROMs programme 
(7)
. With the increasing use of PROMs used as primary outcomes in clinical trials, it is, 
therefore, relevant that their use is rigorously assessed.  
This study has identified that, with current levels of evidence, it is not appropriate to 
recommend any PROMs for LET studies in UK populations. Though the OES, PRTEE and 
DASH show potential as patient-reported measures, with domains likely to be appropriate 
in LET, further assessment is required in UK populations to quantify their validity, reliability, 
responsiveness and patient acceptability.     
 
Take home messages 
There is some evidence for the psychometric properties of OES, PRTEE and DASH PROMs in 
the assessment of patients with Lateral Elbow Tendinopathy. Robust evidence on the 
validity, reliability and responsiveness of any PROM in UK populations of Lateral Elbow 
Tendinopathy patients is lacking.  
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Fig 1: PRISMA Flowchart of the systematic literature review. 
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* All measures were developed for English-speaking adults of either gender. $ All measures were fully standardised. 
Table 1: Outcome measures for the assessment in Lateral Elbow Tendinopathy (LET) with psychometric evaluation in UK population 
Outcome measure Country of 
origin 
Exclusively Patient Reported 
(no. items) 
Construct  
(no. items) 
Population* Measurement model 
$ 
UK LET assessment 
Oxford Elbow Score (OES) 
(23)
 
 
 
United 
Kingdom 
Yes (12) A1. Symptoms 
Pain (4) 
A2. Function 
Elbow function (4) 
Psychosocial (4) 
Assessment of outcome 
of surgery of the elbow 
(23)
 
 
C1. Profile 
C2. Psychometric 
C3. Completely 
Standardised 
Surgically treated LET patients make up 11.2% 
(n= 12/107) of the total development and 
validation cohort 
(23, 32, 33)
 
Liverpool Elbow Score (LES)
(24)
 
 
 
United 
Kingdom 
No, physician administered 
(15) 
A1. Symptoms 
Pain (1) 
A2. Function 
Range of motion (4) 
Strength (1) 
Ulnar nerve function (1) 
Activity (8) 
 
B1. Adults 
B2. All genders 
B3. Assessment of elbow 
pathology in tertiary care 
setting 
(24)
 
B4. UK English  
C1. Index 
C2. Psychometric 
C3. Completely 
Standardised 
Tertiary care patients with LET make up 12.7% 
(n=8/63) of the total development and 
validation cohort 
(24)
 
Patient-rated Tennis Elbow 
Evaluation (PRTEE)
(34)
 
 
 
Canada Yes (15) A1. Symptoms 
Pain (5) 
A2. Function 
Activity (10) 
B1. Adults 
B2. All genders 
B3. Lateral Elbow 
Tendinopathy patients 
(34)
 
B4. UK English  
C1. Index 
C2. Psychometric 
C3. Completely 
Standardised 
57 LET patients (100% of cohort) 
(25)
 
 
(PRTEE delivered in a modified form but not 
formally cross-culturally validated) 
Disabilities of the Arm 
Shoulder and Hand (DASH)
(35)
 
 
2x Optional modules 
Work Sporting/performing 
arts 
 
US, Canada, 
Australia 
Yes (30) A1. Symptoms 
Pain (5) 
A2. Function  
Physical function (21) 
Psychosocial (4) 
B1. Adults 
B2. All genders 
B3. Applied to multiple 
elbow pathologies 
(36)
 
B4. UK English 
C1. Index 
C2. Psychometric 
C3. Completely 
Standardised 
Surgically treated LET patients make up 11.2% 
(n= 12/107) of the total development and 
validation cohort 
(23, 32, 33)
.  
Tertiary care patients with LET make up 12.7% 
(n=8/63) of the total development and 
validation cohort 
(24)
 
 
(DASH delivered in original form, without any 
modifications) 
 
(UK English DASH translation available from 
2015 
(28)
)  
Mayo Elbow Performance 
Score (MEPS)
(37)
 
 
Physician administered 
 
8 Items: 
1x pain 
1x Range of motion 
1x Instability 
5x Function 
United 
States 
No, physician administered 
(15)o 
A1. Symptoms 
A2. Function 
B1. Adults 
B2. All genders 
B3. Applied to multiple 
elbow pathologies 
(38)
 
B4. UK English 
C1. Index 
C2. Clinometric 
C3. Completely 
standardised 
Surgically treated LET patients make up 11.2% 
(n= 12/107) of the total development and 
validation cohort 
(23, 32, 33)
 
 
(MEPS delivered in original form, without any 
modifications) 
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Table 2: Studies reporting the use of PROMs in patients with Lateral Elbow Tendinopathy.  
Author Year Title Study Type and Population Outcome measure 
Melikyan, E. Y., et al.  2003 Extracorporeal shock-wave treatment for tennis elbow: a randomised double-blind study RCT 
LET patients who failed conservative 
treatment  
DASH 
Dunkow, P. D., et al. 2004 A comparison of open and percutaneous techniques in the surgical treatment of tennis elbow RCT  
LET patients who failed conservative 
treatment 
DASH* 
Connell, D. A., et al. 2006 Ultrasound-guided autologous blood injection for tennis elbow Prospective Cohort  
LET patients who failed conservative 
treatment 
Nirschl* 
Alizadehkhaiyat, O., et al. 2007 Pain, functional disability, and psychologic status in tennis elbow Cross-sectional  
LET with symptoms lasting >3 months 
DASH 
PRWE 
PRFEQ 
Connell, D., et al. 2009 Treatment of lateral epicondylitis using skin-derived tenocyte-like cells Prospective Pilot Study (Not Randomised)  
LET patients who failed conservative 
treatment 
PRTEE* 
Clarke, A. W., et al. 2010 Lateral elbow tendinopathy: correlation of ultrasound findings with pain and functional 
disability 
Prospective Cohort 
LET who had not undergone invasive 
treatment 
PRTEE* 
Creaney, L., et al. 2011 Growth factor-based therapies provide additional benefit beyond physical therapy in resistant 
elbow tendinopathy: a prospective, single-blind, randomised trial of autologous blood 
injections versus platelet-rich plasma injections 
RCT 
LET patients who failed conservative 
treatment 
PRTEE* 
Nazar, M., et al. 2012 Percutaneous Tennis Elbow Release Under Local Anaesthesia Prospective Cohort 
LET patients who failed conservative 
treatment 
DASH* 
OES 
Stenhouse, G., et al. 2013 Do blood growth factors offer additional benefit in refractory lateral epicondylitis? A 
prospective randomized pilot trial of dry needling as a stand-alone procedure versus dry 
needling and autologous conditioned plasma 
Prospective Pilot Study (Randomised ) 
LET patients who failed conservative 
treatment 
Nirschl 
Maffulli, G., et al. 2014 Assessment of the Effectiveness of Extracorporeal Shock Wave Therapy (ESWT) For Soft Tissue 
Injuries (ASSERT): An Online Database Protocol 
Online Database Protocol of 
Clinically or Radiologically confirmed LET 
PRTEE* 
Tonks, J. H., et al. 2007 Steroid injection therapy is the best conservative treatment for lateral epicondylitis: 
a prospective randomised controlled trial. 
RCT  
LET patients who had not had treatment 
for the preceding 6 months.  
PRTEE 
* Primary outcome  
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 Table 3:  Adherence to CONSORT reporting standards (PRO extension) of UK-based Lateral Elbow Tendinopathy RCTs.  
CONSORT 2010 statement PRO Extension Studies meeting the requirements 
Structured summary of trial design, 
methods, results, and conclusions 
The PRO should be identified in the abstract as a 
primary or secondary outcome 
1/4  
Specific objectives or hypotheses The PRO hypothesis should be stated and relevant 
domains identified, if applicable 
0/4 
Completely defined pre-specified 
primary and secondary outcome 
measures, including how and when 
they were assessed 
Evidence of PRO Instrument validity and reliability 
should be provided or cited if available, including the 
person completing the PRO and methods of data 
collection (paper, telephone, electronic, other) 
0/4 (validity of PROM in UK population) vs 2/4 (validity 
of PROM in another LET population) 
1/4 (data collection method) 
Statistical methods used to compare 
groups for primary and secondary 
outcomes 
Statistical approaches for dealing with missing data 
are explicitly stated 
0/4 
Trial limitations addressing sources of 
potential bias, imprecision, and, if 
relevant multiplicity of analyses 
PRO-specific limitations and implications for 
generalisability and clinical practice should be 
discussed 
0/4 
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Appendix 1: 
 
Search Strategy – MEDLINE – Run 1/5/2017 
Medline 
1. exp Elbow/ 
2. elbow.tw. 
3. exp Elbow joint/ 
4. exp Tennis Elbow/ 
5. epicondylitis.tw. 
6. common extensor origin.tw. 
7. epicondylalgia.tw. 
8. 1 or 2 or 3 or 4 or 5 or 6 or 7  
9. exp "Outcome Assessment (Health Care)"/ 
10. (Outcome? adj2 assessment).tw. 
11. patient reported outcome?.tw. 
12. outcome? measure?.tw. 
13. exp health status/ 
14. health status.tw. 
15. exp "quality of life"/ 
16. quality of life.tw. 
17. (QL or QoL or HRQL or HRQoL).tw. 
18. (function* adj2 (status or psychological or mental or physical or social)).tw. 
19. disabilit*.tw. 
20. exp "Activities of Daily Living"/ 
21. activities of daily living.tw. 
22. (wellbeing or well being).tw. 
23. exp happiness/ 
24. (happi* or happy).tw. 
25. 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24  
26. assessment.tw. 
27. index.tw. 
28. indices.tw. 
29. instrument?.tw. 
30. measure?.tw. 
31. profile?.tw. 
32. rating?.tw. 
33. report*.tw. 
34. scale?.tw. 
35. schedul*.tw. 
36. scor*.tw. 
37. exp health surveys/ 
38. survey?.tw. 
39. 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33 or 34 or 35 or 36 or 37 or 38  
40. (symptom? adj2 (assessment or index or indices or instrument? or measure? or profile? or rating? or 
report* or scale? or schedule? or scor* or survey?)).tw. 
41. 25 or 40 
42. exp Self-Assessment/ 
43. self-assess*.tw. 
44. exp Questionnaires/ 
45. questionnaire?.tw. 
46. self report*.tw. 
47. 42 or 43 or 44 or 45 or 46  
48. (Validation Studies or Comparative Study).pt. or exp psychometrics/ or psychometr*.tw. or 
clinimetr*.tw. or clinometr*.tw. or exp observer variation/ or observer variation.tw. or exp Health 
Status Indicators/ or exp reproducibility of results/ or reproducib*.tw. or exp discriminant analysis/ or 
reliab*.tw. or unreliab*.tw. or valid*.tw. or coefficient.tw. or homogeneity.tw. or homogeneous.tw. or 
internal consistency.tw. or (cronbach* and (alpha or alphas)).tw. or (item and (correlation* or 
selection* or reduction*)).tw. or agreement.tw. or precision.tw. or imprecision.tw. or precise 
values.tw. or test-retest.tw. or (test and retest).tw. or (reliab* and (test or retest)).tw. or stability.tw. or 
interrater.tw. or inter-rater.tw. or intrarater.tw. or intra-rater.tw. or intertester.tw. or inter-tester.tw. 
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or intratester.tw. or intra-tester.tw. or interobserver.tw. or inter-observer.tw. or intraobserver.tw. or 
intraobserver.tw. or intertechnician.tw. or inter-technician.tw. or intratechnician.tw. or intra-
technician.tw. or interexaminer.tw. or inter-examiner.tw. or intraexaminer.tw. or intra-examiner.tw. or 
interassay.tw. or inter-assay.tw. or intraassay.tw. or intra-assay.tw. or interindividual.tw. or inter-
individual.tw. or intraindividual.tw. or intra-individual.tw. or interparticipant.tw. or inter-participant.tw. 
or intraparticipant.tw. or intra-participant.tw. or kappa.tw. or kappa*.tw. or kappas.tw. or 
repeatab*.tw. or ((replicab* or repeated) and (measure or measures or findings or result or results or 
test or tests)).tw. or concordance.tw. or (intraclass and correlation*).tw. or discriminative.tw. or known 
group.tw. or factor analysis.tw. or factor analyses.tw. or dimension*.tw. or subscale*.tw. or (multitrait 
and scaling and (analysis or analyses)).tw. or item discriminant.tw. or interscale correlation*.tw. or 
error.tw. or errors.tw. or individual variability.tw. or (variability and (analysis or values)).tw. or 
(uncertainty and (measurement or measuring)).tw. or standard error of measurement.tw. or 
sensitiv*.tw. or responsive*.tw. or ((minimal or minimally or clinical or clinically) and (important or 
significant or detectable) and (change or difference)).tw. or (small* and (real or detectable) and 
(change or difference)).tw. or meaningful change.tw. or ceiling effect.tw. or floor effect.tw. or Item 
response model.tw. or IRT.tw. or Rasch.tw. or Differential item functioning.tw. or DIF.tw. or computer 
adaptive testing.tw. or item bank.tw. or cross-cultural equivalence.tw. 
49. 39 or 47 or 48 
50. 41 and 49 
51. (Oxford elbow score or Liverpool Elbow Score or Elbow Self-Assessment Score or Elbow Function 
Assessment or (American Shoulder and Elbow Surgeons-elbow) or (Modified American Shoulder and 
Elbow Surgeons) or Mayo Elbow Performance Score or Hospital for Special Surgery score or Hospital for 
Special Surgery short version or patient-rated elbow evaluation or Patient-Rated Tennis Elbow 
Evaluation or Elbow Functional Assessment or (Disabilities of the Arm, Shoulder and Hand 
questionnaire) or subjective elbow value or (Broberg and Morrey) or Ewald).mp. or Pritchard.tw. 
[mp=ti, ab, ot, nm, hw, kf, px, rx, ui, tn, dm, mf, dv, kw] 
52. (OES or LES or ESAS or ASES or ASES-e or MEP or PREE or PRTEE or EFA or DASH or quickDASH).mp. 
[mp=ti, ab, ot, nm, hw, kf, px, rx, ui, tn, dm, mf, dv, kw] 
53. 8 and 52 
54. 8 and 50 
55. 51 or 53 or 54 
56. exp ANIMALS/ not humans.sh. 
57. 55 not 56 
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Br. 2008;90(4):466-73. 
2. Sathyamoorthy P, Kemp G, Rawal A, Rayner V, Frostick S. Development and validation of an 
elbow score. Rheumatology. 2004;43(11):1434-40. 
3. Dawson J, Doll H, Boller I, Fitzpatrick R, Little C, Rees J, et al. Comparative responsiveness 
and minimal change for the Oxford Elbow Score following surgery. Qual Life Res. 
2008;17(10):1257-67. 
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